Cancer Management and Research
Volume 14, 2022 - Issue
Open access
130
Views
3
CrossRef citations to date
0
Altmetric
REVIEW
Optimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights
Mairi W Lucas1 Royal College of Surgeons in Ireland, St Stephen’s Green, Dublin, Ireland
& Catherine M Kelly2 Mater Private Hospital, Dublin, IrelandCorrespondence[email protected]
https://orcid.org/0000-0001-8355-6714
Pages 2493-2506
|
Published online: 27 Nov 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.